ARROWHEAD PHARMACEUTICALS, INC. Construction in Progress, Gross
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) had Construction in Progress, Gross of $166.66 million as of 2023-09-30, per its 10-K filed 2023-11-29.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:ConstructionInProgressGross · last filed 2023-11-29
- 2023-09-30: Construction in Progress, Gross $166.66M.
- 2023-06-30: Construction in Progress, Gross $118.28M.
- 2023-03-31: Construction in Progress, Gross $127.22M.
- 2022-12-31: Construction in Progress, Gross $90.22M.
| Period end | Construction in Progress, Gross |
|---|---|
| 2023-09-30 | $166.66M 10-K · filed 2023-11-29 |
| 2023-06-30 | $118.28M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $127.22M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $90.22M 10-Q · filed 2023-02-06 |
| 2022-09-30 | $56.37M 10-K · filed 2023-11-29 |
| 2022-06-30 | $22.34M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $6.41M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $2.15M 10-Q · filed 2022-02-02 |
| 2021-09-30 | $345.00K 10-K · filed 2022-11-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |